Heating elements for thermally-driven phase transition implantable micropump

    公开(公告)号:US12290660B2

    公开(公告)日:2025-05-06

    申请号:US17274760

    申请日:2019-12-31

    Abstract: An apparatus includes an enclosure containing a hermetically sealed region, the enclosure configured to be implanted on or within a recipient. The apparatus further includes circuitry within the hermetically sealed region and configured to generate signals. The apparatus further includes at least one heating element configured to receive the signals and to generate heat in response to the signals. The apparatus further includes at least one flow control element outside the hermetically sealed region and configured to respond to the heat by controlling a flow of liquid through at least one cannula to controllably administer the liquid internally to the recipient.

    Implant infection control
    7.
    发明授权

    公开(公告)号:US10537743B2

    公开(公告)日:2020-01-21

    申请号:US15158136

    申请日:2016-05-18

    Abstract: Embodiments presented herein are generally directed to a perioperative implant cover configured to cover at least a portion of an implantable component during portions of the perioperative period (i.e., preoperative, intraoperative, and postoperative phases of surgery) in which the implantable component is susceptible to bacteria contamination. By covering the implantable component during these portions of the perioperative period, the cover reduces the possibility of bacteria contamination and subsequent perioperative colonization.

    LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES

    公开(公告)号:US20220362380A1

    公开(公告)日:2022-11-17

    申请号:US17294521

    申请日:2020-11-10

    Abstract: Presented herein are techniques for localized release of systemically circulating therapeutic substances, which combine many of the advantages of systematic and localized administration, while eliminating many of the associated drawbacks. More specifically, in accordance with the techniques presented herein, an electro-responsive biomaterial is systemically administered to a recipient of an electrically-stimulating implantable medical device. The electro-responsive biomaterial comprises a therapeutic substance that is only activated (e.g., released) in the presence of an electromagnetic field generated by the electrically-stimulating implantable medical device.

Patent Agency Ranking